These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12153542)

  • 21. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
    Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
    J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice.
    Paul R; Angele B; Sporer B; Pfister HW; Koedel U
    J Neuroimmunol; 2004 Jul; 152(1-2):78-82. PubMed ID: 15223240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entorhinal cortex lesion in the mouse induces transsynaptic death of perforant path target neurons.
    Kovac AD; Kwidzinski E; Heimrich B; Bittigau P; Deller T; Nitsch R; Bechmann I
    Brain Pathol; 2004 Jul; 14(3):249-57. PubMed ID: 15446579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
    Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
    J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
    Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
    FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained lipopolysaccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system.
    Matute-Bello G; Winn RK; Martin TR; Liles WC
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):358-61. PubMed ID: 15013988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury.
    Kim MJ; Lim HS; Yoo YB; Lee YI; Hahm DH; Lee HJ; Jung KW; Kim JW; Yoe SM; Chung DC; Chang YP
    Comp Med; 2007 Dec; 57(6):581-9. PubMed ID: 18246871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FasL-Fas interactions regulate neovascularization in the cornea.
    Stuart PM; Pan F; Plambeck S; Ferguson TA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):93-8. PubMed ID: 12506060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
    Li-Weber M; Krammer PH
    Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system.
    Eichhorst ST; Müerköster S; Weigand MA; Krammer PH
    Cancer Res; 2001 Jan; 61(1):243-8. PubMed ID: 11196169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
    Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.
    Ng CS; Lo ST; Chan JK
    Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis.
    Embree-Ku M; Venturini D; Boekelheide K
    Biol Reprod; 2002 May; 66(5):1456-61. PubMed ID: 11967210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators.
    Grosjean MB; Lenzlinger PM; Stahel PF; Yatsiv I; Shohami E; Trentz O; Kossmann T; Morganti-Kossmann MC
    Histol Histopathol; 2007 Mar; 22(3):235-50. PubMed ID: 17163398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.